In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.
Just more than a week has gone by since Colossal Biosciences, the company seeking to bring back the woolly mammoth, revealed it had produced three live dire wolves puppies – Remus, Romulus and ...
The company claiming it can restore lost species also wants to patent them. Colossal Biosciences not only wants to bring back the woolly mammoth—it wants to patent it, too. MIT Technology Review has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback